Stock data
Oric Pharmaceuticals, Inc. (ORIC)
Oric Pharmaceuticals, Inc. (ORIC) reported net income of -US$129.47M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$143.00M | -US$129.47M | — |
| 2024 | — | — | -US$142.90M | -US$127.85M | — |
| 2023 | — | — | -US$110.78M | -US$100.70M | — |
| 2022 | — | — | -US$91.77M | -US$89.12M | — |
| 2021 | — | — | -US$78.87M | -US$78.72M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$41.49M | — |
| 2026-03-31 | — | -US$35.77M | — |
| 2025-12-31 | — | -US$30.50M | — |
| 2025-09-30 | — | -US$32.59M | — |
| 2025-06-30 | — | -US$36.35M | — |
| 2025-03-31 | — | -US$30.02M | — |
| 2024-12-31 | — | -US$36.31M | — |
| 2024-09-30 | — | -US$34.57M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.